JC
XENE icon

JBF Capital’s Xenon Pharmaceuticals XENE Stock Holding History

JBF Capital’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-40,000
Closed -$528K – 148
2018
Q3 		$528K Hold
40,000
– – 0.08% 45
2018
Q2 		$368K Buy
+40,000
New +$249K 0.06% 59
2016
Q2 		– Sell
-68,690
Closed -$480K – 143
2016
Q1 		$480K Hold
68,690
– – 0.06% 52
2015
Q4 		$552K Hold
68,690
– – 0.07% 51
2015
Q3 		$567K Buy
+68,690
New +$682K 0.08% 56

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JBF Capital's XENE Position: Q4 2018 in Review

JBF Capital sold out of Xenon Pharmaceuticals (XENE) in Q4 2018, closing a stake of 40,000 shares — an estimated $528K sold.

JBF Capital first reported a position in XENE in Q3 2015 and held it in 5 quarters. The position peaked at $567K in Q3 2015. 58 funds tracked by Wall St. Rank hold XENE as of Q4 2018.

  • JBF Capital reported no remaining Xenon Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • JBF Capital sold 40,000 Xenon Pharmaceuticals shares in Q4 2018, an estimated $528K.
  • JBF Capital first reported a position in Xenon Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • JBF Capital's Xenon Pharmaceuticals position peaked at $567K in Q3 2015.
  • 58 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2018.

Based on JBF Capital's 13F filing for Q4 2018, filed 12 Feb 2019.